SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-018589
Filing Date
2023-11-09
Accepted
2023-11-09 16:18:17
Documents
102
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q irwd-20230930x10q.htm   iXBRL 10-Q 2270540
2 EX-10.1 irwd-20230930xex10d1.htm EX-10.1 64272
3 EX-31.1 irwd-20230930xex31d1.htm EX-31.1 16582
4 EX-31.2 irwd-20230930xex31d2.htm EX-31.2 16641
5 EX-32.1 irwd-20230930xex32d1.htm EX-32.1 7984
6 EX-32.2 irwd-20230930xex32d2.htm EX-32.2 8419
  Complete submission text file 0001558370-23-018589.txt   10394645

Data Files

Seq Description Document Type Size
7 EX-101.SCH irwd-20230930.xsd EX-101.SCH 84974
8 EX-101.CAL irwd-20230930_cal.xml EX-101.CAL 85802
9 EX-101.DEF irwd-20230930_def.xml EX-101.DEF 352216
10 EX-101.LAB irwd-20230930_lab.xml EX-101.LAB 623994
11 EX-101.PRE irwd-20230930_pre.xml EX-101.PRE 561585
96 EXTRACTED XBRL INSTANCE DOCUMENT irwd-20230930x10q_htm.xml XML 1815750
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 231392757
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences